m+Medelevator.RU
← Поиск публикаций
Nature cell biology · 2025

Metastatic medulloblastoma remodels the local leptomeningeal microenvironment to promote further metastatic colonization and growth.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Abeysundara Namal, Rasnitsyn Alexandra, Fong Vernon, Bahcheli Alexander, Van Ommeren Randy, Juraschka Kyle, Vladoiu Maria, Ong Winnie, Livingston Bryn, de Antonellis Pasqualino, Ly Michelle, Holgado Borja López, Sirbu Olga, Bahrampour Shahrzad, Min Hyun-Kee, Fan Jerry, Nor Carolina, Visvanathan Abhirami, Zhang Jiao, Wang Hao, Qin Lei, Huang Ning, Pallotta Jonelle, Douglas Tajana, Mak Esta, Su Haipeng, Ng Karen, Zhang Kevin Yang, Daniels Craig, Lucas Calixto-Hope G, Eberhart Charles G, Liu Hailong, Jiang Tao, Notta Faiyaz, Ramaswamy Vijay, Reimand Jüri, Gallo Marco, Rich Jeremy N, Wu Xiaochong, Huang Xi, Taylor Michael D

Аннотация

Leptomeningeal metastases are the major source of morbidity and mortality for patients with medulloblastoma. The biology of the leptomeningeal metastases and the local tumour microenvironment are poorly characterized. Here we show that metastasis-associated meningeal fibroblasts (MB-MAFs) are transcriptionally distinct and signal extensively to tumour cells and the tumour microenvironment. Metastatic cells secrete platelet-derived growth factor (PDGF) ligands into the local microenvironment to chemotactically recruit meningeal fibroblasts. Meningeal fibroblasts are reprogrammed to become MB-MAFs, expressing distinct transcriptomes and secretomes, including bone morphogenetic proteins. Active bone morphogenetic protein signalling and co-implantation of tumour cells with MB-MAFs enhances the colonization of the leptomeninges by medulloblastoma cells and promotes the growth of established metastases. Furthermore, treatment of patient-derived xenograft mice with a PDGF-receptor-α neutralizing antibody enhances overall survival in vivo. Collectively, our results define a targetable intercellular communication cascade in the metastatic niche to treat leptomeningeal disease.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты